These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23807405)

  • 21. [Burden of acute rotavirus gastroenteritis (RV-AGE) in Germany: a comparison of federal statistics and epidemiological data].
    Forster J; Hammerschmidt T
    Gesundheitswesen; 2007 Apr; 69(4):227-32. PubMed ID: 17533565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
    Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the potential risks and benefits of infant rotavirus vaccination in England.
    Clark A; Jit M; Andrews N; Atchison C; Edmunds WJ; Sanderson C
    Vaccine; 2014 Jun; 32(29):3604-10. PubMed ID: 24814524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Intussusception After Rotavirus Vaccination.
    Koch J; Harder T; von Kries R; Wichmann O
    Dtsch Arztebl Int; 2017 Apr; 114(15):255-262. PubMed ID: 28468712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between rotavirus vaccination and intussusception in Australian children: A record linkage study.
    Fathima P; Moore HC; Blyth CC; Snelling TL
    Paediatr Perinat Epidemiol; 2020 Sep; 34(5):583-589. PubMed ID: 32163193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany.
    Falkenhorst G; Harder T; Remschmidt C; Terhardt M; Zepp F; Ledig T; Wicker S; Keller-Stanislawski B; Mertens T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1557-64. PubMed ID: 24170085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil.
    Fernandes EG; Sato HK; Leshem E; Flannery B; Konstantyner TC; Veras MA; Patel MM
    Vaccine; 2014 Jun; 32(27):3402-8. PubMed ID: 24736002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendation of rotavirus vaccination and herd effect: a budget impact analysis based on German health insurance data.
    Karmann A; Jurack A; Lukas D
    Eur J Health Econ; 2015 Sep; 16(7):719-31. PubMed ID: 25135769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
    Vesikari T; Prymula R; Schuster V; Tejedor JC; Cohen R; Bouckenooghe A; Damaso S; Han HH
    Pediatr Infect Dis J; 2012 May; 31(5):509-13. PubMed ID: 22228235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of rotavirus infections in children less than 5 years of age: Germany, 2001-2008.
    Koch J; Wiese-Posselt M
    Pediatr Infect Dis J; 2011 Feb; 30(2):112-7. PubMed ID: 20724954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First year experience of rotavirus immunisation programme in Finland.
    Leino T; Ollgren J; Salo H; Tiihonen P; Kilpi T
    Vaccine; 2012 Dec; 31(1):176-82. PubMed ID: 23122991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotavirus vaccines.
    Vesikari T
    Scand J Infect Dis; 2008; 40(9):691-5. PubMed ID: 19086243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rotavirus vaccines: considerations for successful implementation in Europe.
    Van Damme P; Van der Wielen M; Ansaldi F; Desgrandchamps D; Domingo JD; Sanchez FG; Gray J; Haditsch M; Johansen K; Lorgelly P; Lorrot M; Parez N; Reschke V; Rose M
    Lancet Infect Dis; 2006 Dec; 6(12):805-12. PubMed ID: 17123900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recommendations for vaccination against ROTAvirus in PREMature newborns (ROTAPREM)].
    Álvarez Aldeán J; Ares Segura S; Díaz González C; Montesdeoca Melián A; García Sánchez R; Boix Alonso H; Moreno-Pérez D;
    An Pediatr (Engl Ed); 2019 Sep; 91(3):205.e1-205.e7. PubMed ID: 31288982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.